Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Epidemiology of dengue fever in Gabon: Results from a health facility-based fever surveillance in Lambaréné and its surroundings.
Lim, JK; Fernandes, JF; Yoon, I-K; Lee, J-S; Mba, RO; Lee, KS; Namkung, S; Yang, JS; Bae, SH; Lim, S-K; Lell, B; Esen, M; Loembe, MM; Kremsner, PG; ALEXANDER, N; Agnandji, ST;
2021
PLoS neglected tropical diseases, (2021).15 2 10.1371/journal.pntd.0008861.
Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
Yang, J; Zheng, W; Shi, H; Yan, X; Dong, K; You, Q; Zhong, G; Gong, H; Chen, Z; JIT, M; Viboud, C; Ajelli, M; Yu, H;
2021
BMC medicine, (2021).19 1 10.1186/s12916-021-01923-8.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; GALLAGHER, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00128-6.
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
ISHOLA, D; MANNO, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00125-0.
Infection patterns of endemic human coronaviruses in rural households in coastal Kenya.
Nyaguthii, DM; Otieno, GP; Kombe, IK; Koech, D; Mutunga, M; MEDLEY, GF; Nokes, DJ; Munywoki, PK;
2021
Wellcome Open Research, (2021).6, 10.12688/wellcomeopenres.16508.1.
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
PREM, K; Choi, YH; Bénard, É; Burger, E; Hadley, L; Laprise, J-F; Regan, MC; Drolet, M; Sy, S; Abbas, K; Portnoy, A; Kim, J; Brisson, M; JIT, M;
2021
medRxiv (2021). 10.1101/2021.02.08.21251186.
A regional suitable conditions index to forecast the impact of climate change on dengue vectorial capacity.
Davis, C; Murphy, AK; Bambrick, H; Devine, GJ; Frentiu, FD; YAKOB, L; Huang, X; Li, Z; Yang, W; Williams, G; Hu, W;
2021
Environmental research, (2021).195, 10.1016/j.envres.2021.110849.
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
LIU, Y; Morgenstern, C; Kelly, J; LOWE, R; CMMID COVID-19 Working Group,; JIT, M;
2021
BMC Medicine, (2021).19 1 10.1186/s12916-020-01872-8.
Using a household structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic.
Fyles, M; Fearon, E; Overton, C; University of Manchester COVID-19 Working Group,; Wingfield, T; MEDLEY, G; Hall, I; Pellis, L; House, T;
2021
medRxiv (2021). 10.1101/2021.02.03.21250992.
Human, animal, water source interactions and leptospirosis in Thailand.
Narkkul, U; Thaipadungpanit, J; Srisawat, N; RUDGE, JW; Thongdee, M; Pawarana, R; Pan-Ngum, W;
2021
Scientific reports, (2021).11 1 10.1038/s41598-021-82290-5.